Logo

MedTek21 Version 4.0

Jul 26, 2018

MedTek21 has introduced version 4.0 of its eponymous medication management platform for precision medicine, which includes drug-to-gene monitoring. The new release adds reporting for patients at risk for harmful pharmacogenomic interactions as well as real-time alerts either through electronic health records systems or a standalone application. MedTek21 version 4.0 also features two-way integration with Epic Systems and Cerner EHRs and several popular pharmacy information systems. 

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.